Tarit K. Banerjee, M.D.
Tarit
K. Banerjee, MD has recently retired as Oncology Research
Director at Marshfield Clinic, Marshfield, WI. Dr. Banerjee has
served as a Clinical Associate Professor in Medicine at the
University School of Medicine and Public Health, Madison, WI,
Assistant Medical Director of Hospice Program of St. Joseph`s
Hospital of Marshfield, WI, and Clinical Associate of Oncology
at Edmonton, University Hospital of Alberta, Canada. He had been
associated with ECOG since 1974 and had been Principal
Investigator of NCI awarded Marshfield CCOP since 1983 until his
retirement. During his years at Marshfield, Dr. Banerjee also
participated with NSABP, RTOG, GOG, COG, URCC, MD Anderson CCOP
and with Cancer Treatment and Cancer Control Protocol Studies.
He also took part as a member in the executive committee of MDA
CCOP and was a member of ECOG Symptom Control Consortium. His
particular interest includes solid tumor malignancy and cancer
control research aimed at improving quality of life, symptom
control and cancer prevention.
Dr. Banerjee
received his medical degree at Calcutta National Medical
College, India. He completed his rotating internship in New
Delhi, India, Medical Residency in Lutheran/Cleveland Metro
General Hospital, Cleveland, Ohio, and Cancer Research
Fellowship at Roswell Park Memorial Institute, Buffalo, N.Y. He
is Board Certified in Internal Medicine and Medical Oncology. He
received his Fellowship of the American College of Physicians
and the Royal College of Physicians of Canada (FRCP-C) by
written and oral examination. He is emeritus member of American
College of Physicians and American Society of Clinical Oncology
as well as lifetime member of Indian Medical Association. He had
received several recognitions from regional division of American
Cancer Society, NCI, ECOG, NSABP, MD Anderson CCOP, for his
contribution in advancing cancer treatment and cancer control
clinical trials in the community setting. In his early career he
performed research in leukocyte mobilization in normal and
diseased subjects as well as human tumor cell clonogenic assay.